{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:19:56Z","timestamp":1793395196460,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":396,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000404","name":"Foundation for Liver Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000404","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009253","name":"European Association for the Study of the Liver","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009253","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>The pathogenesis of hepatitis C virus (HCV) infection is strongly influenced by the nature of the host's antiviral immunity. Counterintuitively, elevated serum concentrations of C-X-C chemokine 10 (CXCL10), a potent chemoattractant for antiviral T-cells and NK-cells, are associated with poor treatment outcomes in patients with chronic HCV. It has been reported that an N-terminal truncated form of CXCL10, generated by the protease dipeptidylpeptidase 4 (DPP4), can act as chemokine antagonist. We sought to investigate CXCL10 antagonism in the clinical outcome and evolution of acute HCV infection. We collected serial blood samples from 16 patients, at the clinical onset of acute HCV infection and at 12 standardized follow-up timepoints over the first year. Intact and truncated CXCL10 and DPP4 activity were quantified in all longitudinal samples. In addition, NK-cell frequency\/phenotype, and HCV-specific T-cell responses were assessed. Subjects developing chronicity (n = 11) had higher concentrations of CXCL10 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), which was predominantly in a truncated form (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.036) compared to patients who spontaneously resolved infection (n = 5). Truncated CXCL10 correlated with HCV-RNA (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.40, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and DPP4 activity (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.53, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Subjects who resolved infection had a higher frequency of HCV-specific interferon-gamma (IFN\u03b3)-producing T-cells (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.017) and predominance of cytotoxic NK-cells (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) compared to patients who became chronic. Patients who became persistently infected had higher proportions of cytokine-producing NK-cells, which were correlated with concentrations of truncated CXCL10 (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.92, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: This study provides the first evidence of chemokine antagonism during acute HCV infection. We suggest that the DPP4-CXCL10 axis inhibits antiviral innate and adaptive host immunity and favors establishment of viral persistence. (Hepatology 2014;60:487\u2013496)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.27139","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T08:16:35Z","timestamp":1395821795000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":48,"title":["Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection"],"prefix":"10.1097","volume":"60","author":[{"given":"Antonio","family":"Riva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armanda","family":"Casrouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvydas","family":"Ambrozaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai V.","family":"Naoumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20250207","doi-asserted-by":"crossref","first-page":"415425","DOI":"10.1016\/j.clim.2009.02.001","article-title":"Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.","volume":"131","author":"Pachiadakis","year":"2009","journal-title":"Clin Immunol"},{"key":"R3-10-20250207","doi-asserted-by":"crossref","first-page":"283292","DOI":"10.1111\/j.1365-2567.2007.02577.x","article-title":"Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virusspecific CD4 Tcell proliferation in patients with hepatitis C virus infection.","volume":"121","author":"Della Bella","year":"2007","journal-title":"Immunology"},{"key":"R4-10-20250207","doi-asserted-by":"crossref","first-page":"776782","DOI":"10.1016\/j.jhep.2005.05.024","article-title":"Relationship between early HCV kinetics and Tcell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.","volume":"43","author":"Tang","year":"2005","journal-title":"J Hepatol"},{"key":"R5-10-20250207","doi-asserted-by":"crossref","first-page":"346355","DOI":"10.1016\/S0016-5085(00)70217-4","article-title":"Hepatitis C virusspecific Tcell reactivity during interferon and ribavirin treatment in chronic hepatitis C.","volume":"118","author":"Cramp","year":"2000","journal-title":"Gastroenterology"},{"key":"R6-10-20250207","doi-asserted-by":"crossref","first-page":"105112","DOI":"10.1016\/j.cyto.2013.04.016","article-title":"CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients.","volume":"63","author":"Ragab","year":"2013","journal-title":"Cytokine"},{"key":"R7-10-20250207","doi-asserted-by":"crossref","first-page":"501508","DOI":"10.1111\/j.1365-2893.2011.01574.x","article-title":"Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.","volume":"19","author":"Warshow","year":"2012","journal-title":"J Viral Hepat"},{"key":"R8-10-20250207","doi-asserted-by":"crossref","first-page":"545553","DOI":"10.1016\/j.jhep.2010.12.033","article-title":"Induction of CXCR3 and CCR5associated chemokines during acute hepatitis C virus infection.","volume":"55","author":"Zeremski","year":"2011","journal-title":"J Hepatol"},{"key":"R10-10-20250207","doi-asserted-by":"crossref","first-page":"15821590","DOI":"10.1128\/JVI.02007-13","article-title":"Direct, interferonindependent activation of the CXCL10 promoter by NFB and interferon regulatory factor 3 during hepatitis C virus infection.","volume":"88","author":"Brownell","year":"2014","journal-title":"J Virol"},{"key":"R11-10-20250207","doi-asserted-by":"crossref","first-page":"21242134","DOI":"10.1002\/hep.26263","article-title":"Plasma interferongammainducible protein10 (IP10) levels during acute hepatitis C virus infection.","volume":"57","author":"Grebely","year":"2013","journal-title":"Hepatology"},{"key":"RU12-10-20250207","doi-asserted-by":"crossref","first-page":"895903","DOI":"10.1086\/507307","article-title":"Interferon (IFN)gammainducible protein10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFNalpha 2a and ribavirin for chronic hepatitis C virus infection.","volume":"194","author":"Romero","year":"2006","journal-title":"J Infect Dis"},{"key":"R13-10-20250207","doi-asserted-by":"crossref","first-page":"308317","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.","volume":"121","author":"Casrouge","year":"2011","journal-title":"J Clin Invest"},{"key":"RU14-10-20250207","doi-asserted-by":"crossref","first-page":"35543561","DOI":"10.1182\/blood.V98.13.3554","article-title":"Aminoterminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.","volume":"98","author":"Proost","year":"2001","journal-title":"Blood"},{"key":"R15-10-20250207","doi-asserted-by":"crossref","first-page":"312320","DOI":"10.1128\/AAC.00467-07","article-title":"Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virusspecific CD4 Tcell reactivity.","volume":"52","author":"Cooksley","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-10-20250207","doi-asserted-by":"crossref","first-page":"13491360","DOI":"10.1016\/j.jhep.2012.07.007","article-title":"Case definitions for acute hepatitis C virus infection: a systematic review.","volume":"57","author":"Hajarizadeh","year":"2012","journal-title":"J Hepatol"},{"key":"R17-10-20250207","doi-asserted-by":"crossref","first-page":"508520","DOI":"10.1016\/j.jhep.2007.01.002","article-title":"Immunological techniques in viral hepatitis.","volume":"46","author":"Rehermann","year":"2007","journal-title":"J Hepatol"},{"key":"R18-10-20250207","doi-asserted-by":"crossref","first-page":"395397","DOI":"10.1002\/hep.21127","article-title":"NK cells: natural born killers in the conflict between humans and HCV.","volume":"43","author":"Koziel","year":"2006","journal-title":"Hepatology"},{"key":"R19-10-20250207","doi-asserted-by":"crossref","first-page":"17491755","DOI":"10.1086\/593337","article-title":"Hepatitis C virus (HCV)specific T cell responses in injection drug users with apparent resistance to HCV infection.","volume":"198","author":"Thurairajah","year":"2008","journal-title":"J Infect Dis"},{"key":"R20-10-20250207","doi-asserted-by":"crossref","first-page":"123137","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology.","volume":"20","author":"Farag","year":"2006","journal-title":"Blood Rev"},{"key":"R21-10-20250207","doi-asserted-by":"crossref","first-page":"295304","DOI":"10.1016\/j.immuni.2005.01.013","article-title":"A human CD34() subset resides in lymph nodes and differentiates into CD56bright natural killer cells.","volume":"22","author":"Freud","year":"2005","journal-title":"Immunity"},{"key":"R22-10-20250207","doi-asserted-by":"crossref","first-page":"1236512374","DOI":"10.1128\/JVI.79.19.12365-12374.2005","article-title":"Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.","volume":"79","author":"Meier","year":"2005","journal-title":"J Virol"},{"key":"R23-10-20250207","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar2284","article-title":"Serum IL15 in patients with early systemic sclerosis: a potential novel marker of lung disease.","volume":"9","author":"Wuttge","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R24-10-20250207","first-page":"186194","article-title":"Characterization of serum interleukin15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker.","volume":"21","author":"Lamana","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"R25-10-20250207","first-page":"404410","article-title":"Relationship of interferoninducible protein10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype4.","volume":"25","author":"AlAshgar","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R27-10-20250207","doi-asserted-by":"crossref","first-page":"e56991","DOI":"10.1371\/journal.pone.0056991","article-title":"Impact of soluble CD26 on treatment outcome and hepatitis C virusspecific T cells in chronic hepatitis C virus genotype 1 infection.","volume":"8","author":"Soderholm","year":"2013","journal-title":"PLoS ONE"},{"key":"R28-10-20250207","doi-asserted-by":"crossref","first-page":"574578","DOI":"10.1016\/j.bbrc.2010.12.037","article-title":"Visualization of the structures of the hepatitis C virus replication complex.","volume":"404","author":"Chan","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"R29-10-20250207","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.3810\/pgm.2009.01.1953","article-title":"Overview of the gliptin class (dipeptidyl peptidase4 inhibitors) in clinical practice.","volume":"121","author":"Bohannon","year":"2009","journal-title":"Postgrad Med"},{"key":"R30-10-20250207","doi-asserted-by":"crossref","first-page":"34483457","DOI":"10.1002\/eji.200324251","article-title":"Hepatitis C virus nonstructural protein 4 suppresses Th1 responses by stimulating IL10 production from monocytes.","volume":"33","author":"Brady","year":"2003","journal-title":"Eur J Immunol"},{"key":"R31-10-20250207","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1016\/j.jhep.2013.03.003","article-title":"Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.","volume":"59","author":"Oliviero","year":"2013","journal-title":"J Hepatol"},{"key":"R32-10-20250207","first-page":"3758","article-title":"Role of chemokines in the biology of natural killer cells.","volume":"341","author":"Maghazachi","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"R33-10-20250207","doi-asserted-by":"crossref","first-page":"64776482","DOI":"10.4049\/jimmunol.166.11.6477","article-title":"Unique subpopulations of CD56 NK and NKT peripheral blood lymphocytes identified by chemokine receptor expression repertoire.","volume":"166","author":"Campbell","year":"2001","journal-title":"J Immunol"},{"key":"R34-10-20250207","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.4049\/jimmunol.179.1.89","article-title":"CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.","volume":"179","author":"Chan","year":"2007","journal-title":"J Immunol"},{"key":"R35-10-20250207","first-page":"209239","article-title":"Interleukin2, interleukin15, and their roles in human natural killer cells.","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv Immunol"},{"key":"R36-10-20250207","doi-asserted-by":"crossref","first-page":"458467","DOI":"10.1016\/j.jhep.2009.05.030","article-title":"Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.","volume":"51","author":"Bonorino","year":"2009","journal-title":"J Hepatol"},{"key":"R37-10-20250207","doi-asserted-by":"crossref","first-page":"176183","DOI":"10.1023\/A:1015476114409","article-title":"Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatmentnaive HIV1seropositive individuals.","volume":"22","author":"Tarazona","year":"2002","journal-title":"J Clin Immunol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27139","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201408000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:49:07Z","timestamp":1738946947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201408000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27139","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}